
    
      PROTOCOL OUTLINE: This is a randomized, double blind, placebo controlled, parallel study.

      Patients are randomized to receive either L-baclofen or placebo orally at increasing daily
      doses for 1 week. Patients then continue to receive the maximum dosage acceptable for a 1
      week maintenance period.

      Patients, thereafter, may enroll in a long term open label study with L-baclofen.

      Patients are followed at 1, 3, 6, 9, and 12 months.

      Completion date provided represents the completion date of the grant per OOPD records
    
  